Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

AGM & Interim Management Statement

22 Apr 2009 10:01

RNS Number : 9694Q
Flying Brands Limited
22 April 2009
 



22 April 2009

Flying Brands Limited

AGM & Interim Management Statement 

Flying Brands Limited ("the Group"), the Jersey based home shopping group is pleased to announce that all the tabled resolutions were passed at its AGM, held in Jersey earlier today.

Interim Management Statement

Flying Brands Limited announces its Interim Management Statement as required by the FSA's Disclosure and Transparency rules. The financial commentary covers the first thirteen weeks of Flying Brands' current financial year, from 3 January to 3 April 2009. 

Trading

The Group has made a positive start to the current financial year and order intake for the ongoing business is £12.7mup 2.4% on a like for like basis against the same period last year, which is in line with the Board's expectations. We are focussing on tighter cost control and improving operational efficiency and the benefits of this are beginning to come through. However, we expect that the effects of these improvements will be more marked in the rest of the year. We have commenced a restructuring programme and we are targeting a reduction in salaried employee costs (which total approximately £3m) of more than 15%. Once again the full benefits of this programme will not be realised until the second half of the year. 

Flying Flowers' orders to 3 April 2009 were £3.1m compared with £3.3m in the equivalent period last year. However, we have improved margin contribution in this division and this will go a long way to making up for the decline in orders.

The Garden Division Spring 2009 season has started strongly and at 3 April the value of orders taken was £8.4m (2008: £7.8m). This improvement is attributable to a stronger performance from Gardening Direct and we continue to be encouraged by the response to our renewed customer recruitment activities in this area

Revenue for the Entertainment division was £1.3m, which is almost exactly level with the same period in 2008.

The closure of Greeting Direct continues as planned with revenue to 3 April 2009 of £0.8m (2008: £2.3M)

Financial position

There has been no material change in Flying Brands' financial position in the period. The Group's net cash position at 3 April 2009 was £1.0m (2008 net debt: £1.5m). The Group continues to pay down its debt on schedule and to comply with its banking covenants

For further information, please contact:

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Graham Norton, Finance Director

Smithfield Consultants 020 7360 4900

John Kiely

Notes to editors

Jersey based Flying Brands Limited (LSE: FBDU) is a multi brand and multi channel home shopping specialist. Founded in 1981, it was admitted to the Official List of the London Stock Exchange in 1993. The Group operates the following divisions: 

Gifts (Flying Flowers, the UK's largest flowers by post brand,)

Garden (Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations; Garden Bird Supplies, a leading provider of food and accessories for birds and other wildlife)

Entertainment (Listen2, a leading mail order audio books, nostalgic music, DVD and video publisher and distributor; Benham, the first day cover stamps and coins collectables specialist)

More information can be found at: www.flyingbrands.com

Cautionary statement 

This report contains forward- looking statements. These have been made by the Directors in good faith based on the information available to them up to the time of their approval of this report. The Directors can give no assurance that these expectations will prove to have been correct. Due to inherent uncertainties, including both economic and business risk factors underlying such forward looking information, actual results may differ materially from those expressed or implied by these forward looking statements. The Directors undertake no obligation to update any forward looking statements whether as a result of new information, future events or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUUVWRKURSURR
Date   Source Headline
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSLetter to Shareholders
26th Sep 20227:00 amRNSIssue of Warrants to Employees
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn
31st May 202211:00 amRNSPrice Monitoring Extension
31st May 20228:00 amRNSSubmission of FDA 510(k) Application for IB Zero G
30th May 202210:47 amRNSResult of AGM
5th May 20223:00 pmRNSNotice of AGM
3rd May 20222:21 pmRNSIB Broadens Quantitative Mapping
28th Apr 20225:52 pmRNSFinal Results
9th Mar 20223:08 pmRNSIQAI’s Sponsored Phase I Clinical Trial is Open
28th Feb 202211:12 amRNSTotal Voting Rights
8th Feb 20227:00 amRNSIssue of shares to Mayo Clinic
27th Jan 20227:00 amRNSImaging Biometrics LLC - Letter to Shareholders
4th Jan 20229:27 amRNSDirector/PDMR Shareholding
17th Dec 20217:37 amRNSIQ-AI Prepares for Phase I Clinical Trial Launch
13th Dec 202110:32 amRNSDirector's Interest
11th Nov 20218:52 amRNSAgreement with St. Jude Children’s Hospital
2nd Nov 20218:19 amRNSMD ANDERSON ADOPTS IB CLINIC
28th Oct 20214:00 pmRNSLetter to Shareholders
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20212:05 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202112:00 pmRNSPlacing
1st Oct 20218:17 amRNSCase Report on Clinical Value of IB Software
22nd Sep 20217:00 amRNSEU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
17th Sep 20217:00 amRNSIB Software Chosen for Accuracy and Automation
10th Sep 20217:00 amRNSUpdate on Phase I Clinical Trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.